Skip to main content
UHT
NYSE Real Estate & Construction

Universal Health Realty Reports Mixed Q4 & Full-Year 2025 Results, Announces New Development

Analysis by Wiseek.aiReviewed by Editorial Team
Sentiment info
Neutral
Importance info
7
Price
$44.09
Mkt Cap
$604.335M
52W Low
$35.26
52W High
$44.2
Market data snapshot near publication time

summarizeSummary

Universal Health Realty Income Trust reported a slight decline in Q4 and full-year 2025 net income and FFO, impacted by a vacated medical office building, but announced a new $34 million medical plaza development.


check_boxKey Events

  • Q4 2025 Financial Results

    Net income for Q4 2025 was $4.3 million ($.31 per diluted share), down from $4.7 million ($.34 per diluted share) in Q4 2024. FFO was $11.74 million ($.85 per diluted share), a slight decrease from $11.76 million ($.85 per diluted share) in Q4 2024.

  • Full-Year 2025 Financial Results

    Net income for the full year 2025 was $17.6 million ($1.27 per diluted share), down from $19.2 million ($1.39 per diluted share) in 2024. FFO was $47.7 million ($3.44 per diluted share), a slight decrease from $47.9 million ($3.46 per diluted share) in 2024.

  • Impact of Property Vacancy

    The decrease in Q4 net income was primarily due to a $610,000 decrease in net aggregate income at various properties, including a medical office building in Amarillo, Texas, which was vacated in Q4 2025.

  • New Medical Plaza Development

    The company announced a new $34 million, 80,000 square foot medical office building, Palm Beach Gardens Medical Plaza I, with construction commencing in February 2026 and expected completion in Q4 2026. Approximately 75% of the space is subject to a 10-year master flex lease with a UHS subsidiary.


auto_awesomeAnalysis

Universal Health Realty Income Trust reported a slight decline in both fourth quarter and full-year 2025 net income and Funds From Operations (FFO). The Q4 net income decreased by 8.5% and FFO remained largely flat. The full-year net income decreased by 8.3% and FFO by 0.4%. The decline in Q4 net income was primarily attributed to a medical office building in Amarillo, Texas, being vacated upon lease expiration, which the company is actively marketing. This financial update is accompanied by the announcement of a new $34 million medical plaza development in Palm Beach Gardens, Florida, which commenced construction in February 2026 and is expected to be completed in Q4 2026. This new development, with a significant portion already pre-leased, provides a positive long-term growth outlook, offsetting some of the near-term financial headwinds.

At the time of this filing, UHT was trading at $44.09 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $604.3M. The 52-week trading range was $35.26 to $44.20. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed UHT - Latest Insights

UHT
Apr 28, 2026, 6:30 AM EDT
Filing Type: DEF 14A
Importance Score:
7
UHT
Apr 27, 2026, 4:25 PM EDT
Filing Type: 8-K
Importance Score:
7
UHT
Apr 24, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
8
UHT
Feb 25, 2026, 4:25 PM EST
Filing Type: 8-K
Importance Score:
7